![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » bioMérieux Earns CE Mark for COVID-19 Antibody Serology Test
bioMérieux Earns CE Mark for COVID-19 Antibody Serology Test
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
bioMérieux has been granted CE mark certification for its Vidas SARS-CoV-2 IgG II serology test, an assay that can detect anti-SARS-CoV-2 IgG antibodies in the blood.
The test, which provides a semi-quantitative assessment of the level of IgG antibodies present in a blood sample, can help gauge the level of antibody response in a patient after they are vaccinated or infected with the virus.
The assay can be run by hospital and laboratory staff on the company’s Mini Vidas, Vidas and Vidas 3 immunoassay analyzers.
Upcoming Events
-
21Oct